<DOC>
	<DOCNO>NCT01181531</DOCNO>
	<brief_summary>The purpose study determine efficacy treatment cinacalcet manage plasma parathyroid level compare traditional vitamin D therapy , whether give orally intravenously , among hemodialysis subject secondary hyperparathyroidism dos adjust appropriately maintain serum calcium phosphorous level currently recommend range .</brief_summary>
	<brief_title>Compare Efficacy Cinacalcet v Traditional Vitamin D Secondary Hyperparathyroidism ( SHPT ) Among Subjects Undergoing Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>Age ≥ 18 year screen Treated maintenance hemodialysis 3 time week ≥ 3 month prior screen Informed consent provide study candidate For subject NOT receive cinacalcet and/or vitamin D therapy SHPT within 60 day prior enrollment : Plasma PTH level ≥ 450 pg/mL ( 50 pmol/L ) screening , obtained central laboratory , Serum correct total calcium ≥ 8.4 mg/dL ( 2.1 mmol/L ) &lt; 10.2 mg/dL ( 2.55 mmol/L ) screening , obtained central laboratory Parathyroidectomy 12 week date inform consent History seizure within 12 week prior randomization Scheduled kidney transplant Parathyroidectomy anticipate within next 6 month Liver function test &gt; 2 x Upper Limit Normal Prior use bisphosphonates , expect receive bisphosphonates trial Subject previously enrol study General Other investigational procedure exclude Currently enrol another investigational device drug study , less 30 day since end another investigational device drug study ( ) , receive investigational agent ( ) Subject ( male female ) willing use highly effective contraception treatment least one month ( woman ) 3 month ( men ) end treatment Subject pregnant breast feeding , plan become pregnant study within 1 month end treatment Male subject pregnant partner willing use condom treatment least 1 month end treatment Subject know sensitivity intolerance protocol require therapy Subject available protocolrequired study visit , best subject investigator 's knowledge Subject kind disorder , opinion investigator , may compromise ability subject give write informed consent and/or comply require study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Secondary Hyperthyroidism</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Parathyroid</keyword>
	<keyword>PARADIGM</keyword>
</DOC>